/DSOL

DSOL Stock - Drug Free Solution, Inc.

Q: What is the analyst price target for DSOL?

Analyst price target information is not currently available for DSOL.

Q: What is DSOL's market cap?

Market capitalization information is not currently available for DSOL.

Healthcare|Medical - Healthcare Information Services|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DSOL

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.00

52W High$0.10

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2019	FY2018
Revenue	N/A	N/A	N/A	$805	$1,766
Gross Profit	N/A	N/A	N/A	$805	$-9,234
Gross Margin	N/A	N/A	N/A	100.0%	-522.9%
Operating Income	$-6,692	$-12,501	$-26,332	$-1,407,280	$-1,449,300
Net Income	$-6,692	$-12,501	$-26,332	$-1,407,275	$-1,452,408
Net Margin	N/A	N/A	N/A	-174816.8%	-82242.8%
EPS	$0.00	$0.00	$-0.00	$-0.00	$-0.01

Company Overview

Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. Its Living Breath Process is a three-step process that combines self-analysis, breath, and language addressing various markets, including addiction/prevention, self help, emotional wellness, and lifestyle. The company also offers the Living Breath Series of programs with products, education, and services. Its Living Breath Project, through protocols, lifestyle enhancement products, training, and education, focuses on creating community wellness centers, wellness homes, and correctional facility support networks and centers that combine various offerings to diminish addiction and incarceration rates in the United States. The company was formerly known as Living Breath Project, Inc. and changed its name to Drug Free Solution, Inc. in January 2014. Drug Free Solution, Inc. is based in El Segundo, California.

Visit Website

Frequently Asked Questions about DSOL

What is DSOL's current stock price?

Drug Free Solution, Inc. (DSOL) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for DSOL?

No analyst price targets are currently available for this stock.

What sector is Drug Free Solution, Inc. in?

Drug Free Solution, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the OTC exchange.

What is DSOL's market cap?

Drug Free Solution, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does DSOL pay dividends?

No, Drug Free Solution, Inc. does not currently pay a dividend to shareholders.